AZTA logo

AZENTA INC

AZTANASDAQ
๐Ÿ† #2031 by market capEarnings Nov 17US Equity
$33.26โ–ผ $0.13 (โˆ’0.39%)
Live
1hโ–ฒ 0.5%
24hโ–ผ 0.4%
7dโ–ฒ 4.5%
14dโ–ฒ 17.6%
30dโ–ฒ 27.8%
1yโ–ฒ 13.8%
๐ŸฆMarket Cap
$1.53B
Small Cap
๐Ÿ“ˆRevenue Growth (YoY)
+3.5%
Slowing
๐Ÿ“ŠGross Margin
44.0%
Healthy
๐Ÿ’ตFCF Margin
1.6%
Thin
โš–๏ธP/S Ratio
2.5x
Cheap
Otter Score
47
Weak

Trading Snapshot

Day Range
$32.85 โ€“ $33.59
52-Week Range
$15.93 โ€“ $41.73
Volume
$5.04B
Avg Volume
$4.38B
Shares Outstanding
46.1M
Next Earnings
Sep 21, 2026

Fundamentals Snapshot

Annual Revenue
$594M
Last Q Revenue
$161M
P/E Ratio
-12.1
P/S Ratio
2.5x
EPS (TTM)
$-2.71
Dividend Yield
0.00%

Why Investors Own AZTA

  • โœ“High-growth profile โ€” revenue up +19.0% YoY with expanding US Equity exposure.
  • โœ“Healthy economics โ€” 44% gross margin and 15% free-cash-flow margin.
  • โœ“New products and segments could unlock additional revenue streams.
โš ๏ธ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$594Mโ–ฒ +21.3% YoY
Gross Margin (TTM)
43.7%โ–ฒ +3.4% YoY
Operating Income (TTM)
$128Mโ–ฒ +21.3% YoY
Free Cash Flow (TTM)
$90Mโ–ฒ +21.3% YoY

About AZENTA INC

Azenta, Inc. is a global leader specializing in advanced solutions for the discovery, handling, and preservation of life science samples. The company's operations span across North America, Europe, Asia Pacific (including China), and other international markets. Its business is structured into two main reportable segments: Life Sciences Products and Life Sciences Services. The Life Sciences Products division supplies sophisticated automated systems for the cold storage of chemical compounds and biological specimens. This segment also provides crucial equipment for sample preparation and manipulation, along with various consumables and specialized instruments that empower customers to effectively manage samples throughout their entire research and development workflows. Conversely, the Life Sciences Services segment offers a comprehensive suite of programs for sample management, integrated cold chain logistics, cutting-edge informatics, and a range of sample-centric laboratory services. These offerings are vital for propelling scientific research and accelerating drug development. Key services include secure sample banking, advanced genomic sequencing, gene synthesis, laboratory processing, detailed laboratory analysis, biospecimen acquisition, and other essential support functions. Azenta caters to a diverse client base within the life sciences sector, encompassing pharmaceutical companies, biotechnology firms, biorepositories, and academic or private research institutions. Established in 1978, the company, originally known as Brooks Automation, Inc., officially became Azenta, Inc. in December 2021. Its corporate headquarters are located in Chelmsford, Massachusetts.

๐Ÿฆฆ

Otter Score Breakdown

โ“˜
๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿš€Growthโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
โšกMomentumโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Weak
47/100

Analyst Ratings

โ“˜
Consensus
Buy
13 analysts
Strong Buy3
Buy6
Hold4
Sell0
Strong Sell0
Ratings as of Aug 2026

Latest News & Updates